A new robotic surgery technique using a special double-J stent successfully removed a pancreatic tumor while preventing the most common complication, pancreatic fistula, in one patient who recovered without problems. According to Gram Research analysis, the patient resumed eating by day 3 and went home by day 7 with no complications, though this single case report requires larger studies before becoming standard practice.
Surgeons have developed a new robotic surgical technique for removing tumors from the pancreas that may reduce a common and serious complication called pancreatic fistula. The procedure, called central pancreatectomy, removes only the middle section of the pancreas while preserving as much healthy tissue as possible. In this case study, doctors used a special double-J stent (a tiny tube) to help drain fluids after surgery. The patient recovered quickly without complications and went home after one week. While this is just one patient’s experience, the technique shows promise as a safer way to perform this delicate surgery.
Key Statistics
A case report published in Surgical Endoscopy in 2026 documented a fully robotic central pancreatectomy using a double-J pancreatic duct stent that was completed in 357 minutes with only 200 milliliters of blood loss.
The patient in the case report did not develop pancreatic fistula, the most common complication of central pancreatectomy, and was discharged on postoperative day 7 without complications.
At 3-month follow-up imaging, the patient showed no evidence of cancer recurrence or procedure-related complications, and the internal stent had naturally dissolved.
The Quick Take
- What they studied: A new robotic surgery method for removing tumors from the middle of the pancreas using a special drainage tube to prevent fluid buildup after surgery
- Who participated: One patient who had a benign (non-cancerous) tumor in the middle section of their pancreas
- Key finding: The patient recovered without the most common complication (pancreatic fistula), went home after 7 days, and had no problems at 3-month follow-up
- What it means for you: This technique may eventually help pancreas surgery patients recover faster with fewer complications, though more research with many more patients is needed before it becomes standard practice
The Research Details
This is a case report—a detailed description of one patient’s experience with a new surgical technique. The surgeon performed a robotic central pancreatectomy, which means using a robot-assisted machine to remove the middle portion of the pancreas while keeping the rest intact. After removing the tumor, the surgeon reconnected the pancreatic duct (the tube that carries digestive juices) to the stomach using a special double-J stent, which is a tiny flexible tube borrowed from kidney surgery design.
The surgical team documented every step of the procedure on video and reviewed all previous studies about similar minimally invasive pancreas surgeries. They tracked the patient’s recovery closely, measuring fluid drainage and watching for signs of complications. The patient was followed up with imaging scans three months after surgery to confirm everything healed properly.
Central pancreatectomy is valuable because it removes diseased tissue while preserving more healthy pancreas than traditional surgery. However, the biggest challenge has always been preventing pancreatic fistula—a serious leak of digestive juices that occurs in many patients. This case report introduces a new drainage design that may reduce this complication, which is important because it could help patients recover faster and avoid additional treatments.
This is a single case report, which is the lowest level of research evidence. It shows that the technique is possible and safe in one patient, but cannot prove it works better than other methods. The authors appropriately acknowledge that more studies with many patients are needed. The detailed video documentation and 3-month follow-up are strengths. The main limitation is that one patient’s success doesn’t guarantee the technique will work for everyone.
What the Results Show
The robotic surgery was completed successfully without any problems during the operation. The procedure took 357 minutes (about 6 hours) and the patient lost approximately 200 milliliters of blood, which is a small amount for this type of surgery. The patient was able to drink liquids the day after surgery and eat soft foods by day 3, showing rapid recovery.
The most important finding is that the patient did not develop pancreatic fistula, the most common and serious complication of this surgery. Doctors measure this by checking the amylase level (a digestive enzyme) in fluid that drains from the surgical site. On day 5 after surgery, the drain was removed because the fluid no longer showed signs of a leak. The patient went home on day 7 with no complications.
At the 3-month follow-up appointment, imaging scans showed the pancreas had healed properly with no signs of cancer returning or any problems from the surgery. The internal stent had naturally dissolved and was no longer visible on the scans.
The rapid return to eating and drinking is notable because it suggests the stomach-to-pancreas connection healed well. The low blood loss indicates the robotic approach was precise and caused minimal tissue damage. The fact that the internal stent was no longer visible at 3 months suggests it functioned as intended and then dissolved naturally, which is ideal for a temporary drainage device.
Central pancreatectomy is not new, but most surgeries use straight stents for drainage, which can sometimes become blocked or not drain effectively. This case report introduces a double-J stent design (borrowed from urology) as a potential improvement. The authors reviewed previous studies of minimally invasive central pancreatectomy and found this reconstruction approach to be novel. The rapid recovery and absence of fistula in this case are encouraging compared to typical complication rates reported in the medical literature, though direct comparison is limited to one patient.
This is a single case report describing one patient’s experience. One patient cannot prove a technique is safe or effective for everyone. Different patients may have different outcomes based on their age, overall health, tumor size, and other factors. The long-term effects beyond 3 months are unknown. There is no comparison group, so we cannot say this method is better than traditional approaches. The authors appropriately call for larger studies before this becomes standard practice.
The Bottom Line
This technique shows promise but is not yet recommended as standard treatment. Patients with benign pancreatic tumors in the middle of the pancreas should discuss all available surgical options with their surgeon, including traditional approaches and this newer robotic method if available at their hospital. The evidence level is low (one case), so decisions should be individualized. Confidence level: Low—more research needed.
Patients with benign or low-grade tumors in the pancreatic neck or body, surgeons performing pancreatic surgery, and hospitals with robotic surgery capabilities. Patients with advanced cancer or other serious health conditions may not be candidates. People without pancreatic disease do not need to act on this information.
If this technique becomes standard, patients might expect to return to normal eating within 3-5 days and go home within a week, based on this case. Full recovery typically takes 4-6 weeks. However, these timelines are based on one patient and may vary.
Frequently Asked Questions
What is central pancreatectomy and why would someone need it?
Central pancreatectomy removes the middle section of the pancreas to treat benign tumors or low-grade cancers while preserving as much healthy pancreas as possible. This preserves more pancreatic function than removing larger sections, helping patients maintain better digestion and blood sugar control after surgery.
What is pancreatic fistula and why is it a problem after pancreas surgery?
Pancreatic fistula is an abnormal leak of digestive juices from the pancreas after surgery. It’s serious because it can cause infection, fluid buildup, and delayed recovery. This case report’s new stent design may help prevent this complication by improving drainage.
How is robotic surgery different from traditional open pancreas surgery?
Robotic surgery uses smaller incisions and gives surgeons a magnified 3D view and precise instrument control. This can mean less blood loss, less tissue damage, and faster recovery compared to traditional open surgery, as shown in this patient’s rapid return to eating.
Is this new stent technique ready for widespread use?
Not yet. This is one successful case report, which is the lowest level of research evidence. Surgeons need to perform this technique on many more patients and compare it to traditional methods before it becomes standard practice at most hospitals.
How long does recovery take after this type of pancreas surgery?
In this case report, the patient resumed liquids by day 2, soft foods by day 3, and went home by day 7. Full recovery typically takes 4-6 weeks, though individual timelines vary based on age, health, and other factors.
Want to Apply This Research?
- For patients considering or recovering from pancreatic surgery: track daily oral intake progression (liquids only, soft foods, regular diet), drain output if applicable, pain levels (0-10 scale), and return-to-activity milestones
- Patients can use the app to log their surgical recovery timeline, set reminders for follow-up appointments and imaging scans, and document any unusual symptoms to discuss with their surgical team
- Create a recovery checklist tracking: days until liquid diet, days until soft food, days until drain removal, days until discharge, and 3-month imaging results. Compare personal recovery timeline to expected benchmarks
This article describes a single case report of a new surgical technique and should not be considered proof that this method is safe or effective for all patients. Central pancreatectomy is a complex procedure that should only be performed by experienced pancreatic surgeons at specialized medical centers. Patients with pancreatic tumors should discuss all treatment options, including risks and benefits, with their surgical team. This information is educational and not a substitute for professional medical advice, diagnosis, or treatment. Always consult with qualified healthcare providers before making decisions about pancreatic surgery.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.